More than 40 million people are living with a movement disorder, chronic, often painful and debilitating conditions that negatively impact a person's quality of life. These neurological conditions include Parkinson's disease, tics and Tourette's syndrome, tremor, dystonia, spasticity and ataxia among others. Despite the prevalence, movement disorders still go undiagnosed or misdiagnosed with some patients visiting more than 15 doctors over the course of five years before receiving a correct diagnosis. Host Dr. Leslie Lundt reviews movement disorders with Dr. Joeseph Jankovic.
Overview of Movement Disorders
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
More than 40 million people are living with a movement disorder, chronic, often painful and debilitating conditions that negatively impact a person's quality of life. These neurological conditions include Parkinson's disease, tics and Tourette's syndrome, tremor, dystonia, spasticity and ataxia among others. Despite the prevalence, movement disorders still go undiagnosed or misdiagnosed with some patients visiting more than 15 doctors over the course of five years before receiving a correct diagnosis. Host Dr. Leslie Lundt reviews movement disorders with Dr. Joeseph Jankovic.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Cardiology
Phase 3 study results of plozasiran in patients with FCS
<p>Phase 3 study results of plozasiran in patients with FCS</p>
CME/CE
FCS and SHTG: Are We Meeting the Need?
0.25 credits
<p>FCS and SHTG: Are We Meeting the Need?</p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
MinuteCE®
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
1.00 credits
<p>Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D</p>
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
<p>Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF</p>
Cardiology
FINE-HEART Pooled Analysis
<p><span data-teams="true">FINE-HEART Pooled Analysis</span></p>
ACC Action Center
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
<p>Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?